Clinchoice sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-11
Share capital
50,000.00 PLN
Activity description

Clinchoice is a global full-service contract research organization (CRO) that specializes in clinical development, post-marketing support, and functional service support for pharmaceuticals, medical devices, and consumer health products. The company conducts clinical studies, including advanced therapies like Chimeric Antigen Receptor T-cell (CAR-T) therapy targeting solid tumors. Clinchoice provides comprehensive solutions from early clinical development through to post-approval lifecycle management across various therapeutic areas.

Registered address
Gen. Józefa Zajączka 32, 01-510 Warszawa, Poland
Email
Social media

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 458 days for 2024).

  • 2025not filed
  • 202416/10/2026
  • 202303/07/2024
  • 202213/07/2023
  • 202107/11/2022
  • 202013/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 8.0%
Voivodeship · Mazowieckie18,022 / 142,204
Top 13%
Country · Poland65,061 / 496,474
Top 13%

Results vs industry

Revenue
This companyUSD 2.85mMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD -635.03kMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 3.32mMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 2.87mMedianUSD 120.25kAverageUSD 3.90m

Offer

  • Clinical development
  • Clinical operations
  • Biometrics
  • Medical monitoring
  • Safety surveillance
  • Regulatory affairs
  • Medical writing
  • Real-world evidence

Websites

Job offers

The company has its own careers page: clinchoice.com/careers.

Authorized Representatives

Agnieszka Barbara Więcek age 55 – Attorney-in-fact (sole)
Somodipto Basu – Attorney-in-fact (sole)
Xin Ke – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Clinchoice S.r.l.
1,000$13,506.21100%

Beneficial owners

Person

Capital group

The company belongs to the Clinchoice S.R.L. (Italy) group, which is its direct owner.

Bank accounts

Registered as a VAT taxpayer on 2000-07-10.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jan 20, 2012Commercial Companies Code notice
Nov 7, 2011Merger plan

Public aid

4 public aid cases recorded, with a total value of $386,783.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Competitors

Name
Kapadi sp. z o.o.
Biostat sp. z o.o.
Humaneva S.A.
Brillance sp. z o.o.
Pure Clinical sp. z o.o.
Associated Medical Clinical Science Services sp. z o.o.
2kmm sp. z o.o.
Simbec-Orion (Pol) sp. z o.o.
Scientia Cro sp. z o.o.
CTI Clinical Trial and Consulting Services Poland sp. z o.o.

Change history

DateEvent
2025-04-15Name change
2012-11-16Address change
2012-03-26Name change
2007-05-08Share capital increase
2002-01-24Address change

FAQ

Last updated: 2026-10-18